Affiliations: [a] Cognitive Impairment Center, Local Health Authority 9 of Treviso, Treviso, Italy
| [b]
Villa Santa Maria Institute, Tavernerio, Italy
| [c]
Semeion Research Centre of Sciences of Communication, Rome, Italy
Correspondence:
[*]
Correspondence to: Maurizio Gallucci, MD, Cognitive Impairment Center, Local Health Authority 9 of Treviso, Treviso, Italy. Tel.: +39 0422 322021; Fax: +39 0422 322543; E-mail: [email protected].
Abstract: Background:The pharmacological treatment of Alzheimer’s disease (AD) is based largely on cholinesterase inhibitors (ChEI). Objective:To investigate whether or not some non-pharmacological and contextual factors measured prior to starting treatment such as past occupation, lifestyles, marital status, degree of autonomy and cognitive impairment, living alone or with others, and the degree of brain atrophy are associated with a better response to ChEI treatment. Methods:Eighty-four AD and six AD with cerebrovascular disease (AD + CVD) outpatients of Treviso Dementia (TREDEM) Registry, with an average cholinesterase inhibitors treatment length of four years, were considered. The outpatients had undergone a complete evaluation and some non-pharmacological and contextual factors were collected. We defined responder a patient with a delta score T0 – T1 equal or inferior to 2.0 points per year of MMSE and a non-responder a patient with a delta score T0 – T1 superior to 2.0 points per year. In order to identify hidden relationships between variables related to response and non-response, we use a special kind of artificial neural network called Auto-CM, able to create a semantic connectivity map of the variables considered in the study. Results:A higher cognitive profile, a previous intellectual occupation, healthier lifestyles, being married and not living alone, a higher degree of autonomy, and lower degree of brain atrophy at baseline resulted in affecting the response to long-term ChEI therapy. Conclusion:Non-pharmacological and contextual factors appear to influence the effectiveness of treatment with ChEI in the long term.
